Back to resultsFar Infrared Treatment for Alzheimer's Disease
Primary Purpose
Alzheimer Disease
Status
Unknown status
Phase
Phase 1
Locations
Canada
Study Type
Interventional
Intervention
Far Infrared Radiation (5μm to 20μm wavelength)
Sponsored by
About this trial
This is an interventional treatment trial for Alzheimer Disease focused on measuring Acute Confusional Senile Dementia, Alzheimer Type Senile Dementia, SENILE PLAQUES, NEUROFIBRILLARY TANGLES, NEUROPIL THREADS
Eligibility Criteria
Inclusion Criteria:
- People with Alzheimer's disease
Exclusion Criteria:
- None
Sites / Locations
- The Centre for Incurable Diseases
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
1
Arm Description
Far Infrared Radiation
Outcomes
Primary Outcome Measures
Management and Cure of Alzheimer's Disease
Secondary Outcome Measures
Management and Cure of Dementia
Full Information
NCT ID
NCT00599469
First Posted
January 11, 2008
Last Updated
August 14, 2009
Sponsor
GAAD Medical Research Institute Inc.
1. Study Identification
Unique Protocol Identification Number
NCT00599469
Brief Title
Far Infrared Treatment for Alzheimer's Disease
Official Title
Phase 1 Study to Determine the Efficacy of Using Far Infrared Radiation for the Treatment of Alzheimer's Disease.
Study Type
Interventional
2. Study Status
Record Verification Date
August 2009
Overall Recruitment Status
Unknown status
Study Start Date
February 2008 (undefined)
Primary Completion Date
March 2009 (Anticipated)
Study Completion Date
April 2009 (Anticipated)
3. Sponsor/Collaborators
Name of the Sponsor
GAAD Medical Research Institute Inc.
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
Alzheimer's disease is a progressive and fatal brain disease. This study will investigate the use of far infrared radiation treatment for the disease.
Detailed Description
Alzheimer's destroys brain cells, causing problems with memory, thinking and behaviour severe enough to affect work, lifelong hobbies or social life. Alzheimer's gets worse over time and it is fatal.
Alzheimer's, which has no current cure, is the most common form of dementia. It is hereby postulated that far infrared radiation of the central nervous and endocrine systems will help with the management of the disease and possibly cure the disease.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Alzheimer Disease
Keywords
Acute Confusional Senile Dementia, Alzheimer Type Senile Dementia, SENILE PLAQUES, NEUROFIBRILLARY TANGLES, NEUROPIL THREADS
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
1
Arm Type
Other
Arm Description
Far Infrared Radiation
Intervention Type
Radiation
Intervention Name(s)
Far Infrared Radiation (5μm to 20μm wavelength)
Intervention Description
Far Infrared radiation for 30 to 40 minutes per treatment session.
Primary Outcome Measure Information:
Title
Management and Cure of Alzheimer's Disease
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Management and Cure of Dementia
Time Frame
1 year
10. Eligibility
Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
People with Alzheimer's disease
Exclusion Criteria:
None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ken Nedd, M.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kwasi Donyina, Ph.D.
Organizational Affiliation
GAAD Medical Research Institute Inc.
Official's Role
Study Director
Facility Information:
Facility Name
The Centre for Incurable Diseases
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M4V 1L5
Country
Canada
12. IPD Sharing Statement
Learn more about this trial
Far Infrared Treatment for Alzheimer's Disease
We'll reach out to this number within 24 hrs